97 related articles for article (PubMed ID: 22813652)
1. Regulation of the CD4+ T cell allo-immune response by endothelial cells.
Taflin C; Charron D; Glotz D; Mooney N
Hum Immunol; 2012 Dec; 73(12):1269-74. PubMed ID: 22813652
[TBL] [Abstract][Full Text] [Related]
2. Immunological function of the endothelial cell within the setting of organ transplantation.
Taflin C; Charron D; Glotz D; Mooney N
Immunol Lett; 2011 Sep; 139(1-2):1-6. PubMed ID: 21641935
[TBL] [Abstract][Full Text] [Related]
3. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4(+) T cells.
Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
Transplantation; 2006 Mar; 81(5):726-35. PubMed ID: 16534475
[TBL] [Abstract][Full Text] [Related]
4. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
[TBL] [Abstract][Full Text] [Related]
5. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection.
Bishop DK; Shelby J; Eichwald EJ
Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070
[TBL] [Abstract][Full Text] [Related]
6. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
[TBL] [Abstract][Full Text] [Related]
7. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
[TBL] [Abstract][Full Text] [Related]
8. Propagation and characterization of lymphocytes from transplant biopsies.
Duquesnoy RJ; Trager JD; Zeevi A
Crit Rev Immunol; 1991; 10(6):455-80. PubMed ID: 1830745
[TBL] [Abstract][Full Text] [Related]
9. Inflammation and the balance of Treg and Th17 cells in transplant rejection and tolerance.
Hanidziar D; Koulmanda M
Curr Opin Organ Transplant; 2010 Aug; 15(4):411-5. PubMed ID: 20613526
[TBL] [Abstract][Full Text] [Related]
10. Role of tumor endothelium in CD4+ CD25+ regulatory T cell infiltration of human pancreatic carcinoma.
Nummer D; Suri-Payer E; Schmitz-Winnenthal H; Bonertz A; Galindo L; Antolovich D; Koch M; Büchler M; Weitz J; Schirrmacher V; Beckhove P
J Natl Cancer Inst; 2007 Aug; 99(15):1188-99. PubMed ID: 17652277
[TBL] [Abstract][Full Text] [Related]
11. CD154 on the surface of CD4+CD25+ regulatory T cells contributes to skin transplant tolerance.
Jarvinen LZ; Blazar BR; Adeyi OA; Strom TB; Noelle RJ
Transplantation; 2003 Nov; 76(9):1375-9. PubMed ID: 14627918
[TBL] [Abstract][Full Text] [Related]
12. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
[TBL] [Abstract][Full Text] [Related]
13. Allorecognition pathways in transplant rejection and tolerance.
Ali JM; Bolton EM; Bradley JA; Pettigrew GJ
Transplantation; 2013 Oct; 96(8):681-8. PubMed ID: 23715047
[TBL] [Abstract][Full Text] [Related]
14. Allograft rejection in athymic nude rats by transferred T cell subsets. II. The response of naive CD4+ and CD8+ thoracic duct lymphocytes to an isolated MHC class I disparity.
Bell EB; Rejali D; Whitby EH; Sparshott SM; Yang CP
Transplantation; 1990 Oct; 50(4):690-6. PubMed ID: 1977220
[TBL] [Abstract][Full Text] [Related]
15. Local IL-17 production and a decrease in peripheral blood regulatory T cells in an animal model of bronchiolitis obliterans.
Nakagiri T; Inoue M; Morii E; Minami M; Sawabata N; Utsumi T; Kadota Y; Ideguchi K; Tokunaga T; Okumura M
Transplantation; 2010 Jun; 89(11):1312-9. PubMed ID: 20393404
[TBL] [Abstract][Full Text] [Related]
16. [Expression of regulatory T cells and related cytokines in mice allogenic corneal transplantation rejection].
Wang X; LE QH; Hong JX; Xu JJ; Sun XH; Wang WT; Zhuang H
Zhonghua Yan Ke Za Zhi; 2009 Dec; 45(12):1118-26. PubMed ID: 20193436
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma conditioning ex vivo generates CD25+CD62L+Foxp3+ regulatory T cells that prevent allograft rejection: potential avenues for cellular therapy.
Feng G; Wood KJ; Bushell A
Transplantation; 2008 Aug; 86(4):578-89. PubMed ID: 18724229
[TBL] [Abstract][Full Text] [Related]
18. HLA-DQ alloantibodies directly activate the endothelium and compromise differentiation of FoxP3
Cross AR; Lion J; Poussin K; Assayag M; Taupin JL; Glotz D; Mooney N
Kidney Int; 2019 Sep; 96(3):689-698. PubMed ID: 31307777
[TBL] [Abstract][Full Text] [Related]
19. Failure of anti-T cell monoclonal antibodies to prevent acute tumor allograft rejection is associated with their inability to deplete or inactivate T cells at the site of rejection.
Rakhmilevich AL
Transplantation; 1994 Jul; 58(1):72-80. PubMed ID: 7913562
[TBL] [Abstract][Full Text] [Related]
20. Targeting acute allograft rejection by immunotherapy with ex vivo-expanded natural CD4+ CD25+ regulatory T cells.
Xia G; He J; Zhang Z; Leventhal JR
Transplantation; 2006 Dec; 82(12):1749-55. PubMed ID: 17198271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
